We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMPH
RNS Number : 7174D
Mereo BioPharma Group plc
28 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Mereo BioPharma Group PLC the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------- ---------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights No --------------------------------------------------------------------------------------------- ---- An acquisition or disposal of qualifying financial No instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------------------------- ---- An acquisition or disposal of instruments with No similar economic effect to qualifying financial instruments --------------------------------------------------------------------------------------------- ---- An event changing the breakdown of voting rights No --------------------------------------------------------------------------------------------- ---- Other (please Conversion of loan note and issue Yes specify): of equity -------------------------------------------------------- ----------------------------------- ---- 3. Full name of person(s) Invesco Ltd. subject to the notification obligation: (iii) --------------------------------------------------------- ---------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) --------------------------------------------------------- ---------------------------------------- 5. Date of the transaction 26 April 2017 and date on which the threshold is crossed or reached: (v) --------------------------------------------------------- ---------------------------------------- 6. Date on which issuer 28 April 2017 notified: --------------------------------------------------------- ---------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 27% --------------------------------------------------------- ---------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ---------------- ---------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights -------------- ---------------- ---------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ -------------- --------- ------------ ------------ ----------- Ordinary Gbp 0.003 Shares GB00BZ4G2K23 19,932,931 19,932,931 19,521,595 27.64% ---------------- ---------------- -------------- --------- ------------ ------------ ----------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ---------------- -------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) -------------- ---------------- ---------------- ---------------- ------------------------- ----------------------- Nominal Delta -------------- ---------------- ---------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------------ ---------------------------------------------------------------- 19,521,595 27.64% ------------------------------------------------------ ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------- Invesco Asset Management Limited - 19,521,595 Proxy Voting: ---------------------------------------------------------------- 10. Name of the proxy holder: Invesco Ltd. ---------------------------------------------- ---------------- 11. Number of voting rights proxy N/A holder will cease to hold: ---------------------------------------------- ---------------- 12. Date on which proxy holder will N/A cease to hold voting rights: ---------------------------------------------- ---------------- 13. Additional information: ---------------------------------------------- ---------------- 14. Contact name: Philippa Holmes ---------------------------------------------- ---------------- 15. Contact telephone number: 01491 417 447 ---------------------------------------------- ---------------- Note: Annex should only be submitted to the FCA not the issuer Annex: Notification of major interests in share A: Identity of the persons or legal entity subject to the notification obligation ---------------------------------------------------------------------- Full name (including legal form of legal entities) ------------------------------------- ------------------------------- Contact address (registered office for legal entities) ------------------------------------- ------------------------------- Phone number & email ------------------------------------- ------------------------------- Other useful information (at least legal representative for legal persons) ------------------------------------- ------------------------------- B: Identity of the notifier, if applicable ---------------------------------------------------------------------- Full name Invesco (UK) Limited ------------------------------------- ------------------------------- Contact address Registered Address: Perpetual Park, Perpetual Park Drive, Henley-on-Thames.
Oxon. RG9 1HH ------------------------------------- ------------------------------- Phone number & email 01491 417 000 ------------------------------------- ------------------------------- Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------- ------------------------------- C: Additional information ---------------------------------------------------------------------- For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLIPMBTMBATBBR
(END) Dow Jones Newswires
April 28, 2017 07:53 ET (11:53 GMT)
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions